| Tier 1 products are covered with no authorization necessary. Tier 2 authorization criteria
- Trials of all Tier 1 medication that yielded inadequate clinical response or adverse effects, OR
- A unique FDA approved indication not covered by Tier 1 products.
Tier 3 Authorization Criteria: Trials of all Tier 2 medications that yielded inadequate clinical response or adverse effects, OR A unique FDA approved indication not covered by lower Tiered products. Oxytrol (oxybutynin 3.9mg/day patch) Special PA Tier approval criteria:
- An FDA approved diagnosis of overactive bladder; AND
- A patient-specific, clinically significant reason why all lower tiered medications are not appropriate for the member; AND
- A quantity limit of 8 patches every 30 days will apply.
|